262 related articles for article (PubMed ID: 21284143)
1. [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off].
Moberg E
Lakartidningen; 2010 Dec 8-14; 107(49):3120-1. PubMed ID: 21284143
[No Abstract] [Full Text] [Related]
2. Education on sensor-augmented pump use improves glucose control in type 1 diabetic patients.
Thielen V; Place J; Gerbaud S; Scheen A; Bringer J; Renard E
Diabetes Metab; 2010 Apr; 36(2):170-1. PubMed ID: 20153675
[No Abstract] [Full Text] [Related]
3. Using the continuous glucose monitoring system to improve the management of type 1 diabetes.
Bode BW; Hirsch IB
Diabetes Technol Ther; 2000; 2 Suppl 1():S43-8. PubMed ID: 11469631
[No Abstract] [Full Text] [Related]
4. Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK.
Choudhary P; de Portu S; Arrieta A; Castañeda J; Campbell FM
Diabet Med; 2019 Sep; 36(9):1100-1108. PubMed ID: 31134668
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
[TBL] [Abstract][Full Text] [Related]
6. [Self monitoring of blood glucose: tool for successful diabetes therapy].
Hummel M
MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
[No Abstract] [Full Text] [Related]
7. Sensor-augmented insulin-pump therapy in type 1 diabetes.
Diamant M
N Engl J Med; 2010 Nov; 363(21):2070; author reply 2071. PubMed ID: 21083396
[No Abstract] [Full Text] [Related]
8. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump.
Halvorson M; Carpenter S; Kaiserman K; Kaufman FR
J Pediatr; 2007 Jan; 150(1):103-105.e1. PubMed ID: 17188626
[TBL] [Abstract][Full Text] [Related]
9. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D
N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
[No Abstract] [Full Text] [Related]
11. Experience with the Enlite sensor in a multicenter pediatric study.
Evans K; Richardson C; Landry A; Muileboom J; Cormack L; Lawson ML;
Diabetes Educ; 2015 Feb; 41(1):31-7. PubMed ID: 25512220
[TBL] [Abstract][Full Text] [Related]
12. Sensor augmented pump therapy in the management of type 1 diabetes complicated with Addison's disease prior to and during pregnancy.
Vinagre I; Giménez M; Pericot A; Bellart J; Conget I
Endocrinol Nutr; 2014; 61(6):341-3. PubMed ID: 24680974
[No Abstract] [Full Text] [Related]
13. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF
Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123
[TBL] [Abstract][Full Text] [Related]
14. Concept and Implementation of a Novel Patch Pump for Insulin Delivery.
Ulbrich S; Waldenmaier D; Haug C; Freckmann G; Rendschmidt T; Künsting T
J Diabetes Sci Technol; 2020 Mar; 14(2):324-327. PubMed ID: 31452394
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
16. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
[TBL] [Abstract][Full Text] [Related]
17. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472
[TBL] [Abstract][Full Text] [Related]
18. [Future diagnostic possibilities with continuous glucose monitoring and their indications in daily life].
Heinemann L
MMW Fortschr Med; 2008 Oct; 150(44):47-9. PubMed ID: 19024492
[No Abstract] [Full Text] [Related]
19. Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 Subjects.
Walsh J; Roberts R; Weber D; Faber-Heinemann G; Heinemann L
J Diabetes Sci Technol; 2015 Jun; 9(5):1103-10. PubMed ID: 26071425
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring used with an insulin pump: should we recommend it to people with diabetes and can we afford it?
Hitman GA
Diabet Med; 2015 May; 32(5):571. PubMed ID: 25892446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
